DENTSPLY SIRONA (XRAY) Upgraded by Barrington Research to Outperform

Barrington Research upgraded shares of DENTSPLY SIRONA (NASDAQ:XRAY) from a market perform rating to an outperform rating in a report released on Monday morning, Briefing.com Automated Import reports. They currently have $63.00 price objective on the medical instruments supplier’s stock.

Several other analysts also recently weighed in on the stock. HC Wainwright restated a neutral rating and set a $55.00 price objective (up previously from $49.00) on shares of DENTSPLY SIRONA in a research report on Monday. ValuEngine upgraded shares of DENTSPLY SIRONA from a hold rating to a buy rating in a research report on Saturday. Guggenheim began coverage on shares of DENTSPLY SIRONA in a research report on Wednesday, April 17th. They set a neutral rating and a $54.00 price objective for the company. BidaskClub upgraded shares of DENTSPLY SIRONA from a hold rating to a buy rating in a research report on Tuesday, April 16th. Finally, Bank of America began coverage on shares of DENTSPLY SIRONA in a report on Monday, March 18th. They issued a buy rating and a $57.00 target price on the stock. Nine equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. DENTSPLY SIRONA currently has an average rating of Buy and a consensus price target of $53.25.

Shares of NASDAQ:XRAY opened at $54.73 on Monday. The company has a market cap of $12.32 billion, a PE ratio of 27.23, a P/E/G ratio of 2.25 and a beta of 1.11. The company has a quick ratio of 1.27, a current ratio of 1.86 and a debt-to-equity ratio of 0.30. DENTSPLY SIRONA has a twelve month low of $33.93 and a twelve month high of $55.88.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings data on Friday, May 3rd. The medical instruments supplier reported $0.49 earnings per share for the quarter, topping the consensus estimate of $0.39 by $0.10. The business had revenue of $946.20 million during the quarter, compared to the consensus estimate of $925.13 million. DENTSPLY SIRONA had a negative net margin of 26.48% and a positive return on equity of 8.98%. The company’s revenue was down 1.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.45 EPS. On average, equities research analysts forecast that DENTSPLY SIRONA will post 2.33 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which was paid on Friday, April 12th. Investors of record on Friday, March 29th were given a $0.087 dividend. The ex-dividend date was Thursday, March 28th. This represents a $0.35 annualized dividend and a dividend yield of 0.64%. DENTSPLY SIRONA’s dividend payout ratio is presently 17.41%.

In related news, Director Eric Brandt sold 9,160 shares of the business’s stock in a transaction dated Friday, May 3rd. The shares were sold at an average price of $53.45, for a total value of $489,602.00. Following the sale, the director now directly owns 26,003 shares in the company, valued at approximately $1,389,860.35. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 0.62% of the stock is owned by insiders.

Institutional investors have recently added to or reduced their stakes in the stock. Advisor Partners LLC purchased a new stake in shares of DENTSPLY SIRONA in the 4th quarter worth about $367,000. S&CO Inc. boosted its position in shares of DENTSPLY SIRONA by 4.3% in the 1st quarter. S&CO Inc. now owns 57,040 shares of the medical instruments supplier’s stock worth $2,829,000 after buying an additional 2,352 shares in the last quarter. Natixis Advisors L.P. boosted its position in shares of DENTSPLY SIRONA by 30.7% in the 4th quarter. Natixis Advisors L.P. now owns 44,911 shares of the medical instruments supplier’s stock worth $1,671,000 after buying an additional 10,547 shares in the last quarter. Stone Ridge Asset Management LLC boosted its position in shares of DENTSPLY SIRONA by 50.8% in the 4th quarter. Stone Ridge Asset Management LLC now owns 29,170 shares of the medical instruments supplier’s stock worth $1,085,000 after buying an additional 9,825 shares in the last quarter. Finally, AMG National Trust Bank purchased a new stake in shares of DENTSPLY SIRONA in the 4th quarter worth about $1,379,000. Institutional investors and hedge funds own 99.78% of the company’s stock.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.

Featured Article: How do candlesticks reflect price movement?

Analyst Recommendations for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.